CNS vs CVBF
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 06, 2026
CNS
CVBF
Investment Advisor Scores
CVBF
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | CVBF | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.4162 | 11.534 | CVBF |
| PEG Ratio | 1.3439 | 1.4662 | CNS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.1% | 54.1% | CVBF |
| Earnings Growth | 0.0% | 15.8% | CVBF |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.1/100 | 57.6/100 | CVBF |
| Profit Margin | 28.2% | 36.2% | CVBF |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | CVBF |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
DistributionPrice near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
CVBF
NeutralMixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | CNS | CVBF |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.6 | 11.5 |
| Trailing P/E | 22.7 | 15.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.5% |
| Gross Margin | 0.5% | 1.0% |
| Operating Margin | 0.3% | 0.6% |
| EPS | 3.25 | 1.51 |
| Dividend Yield | 0.04% | 0.03% |